Handan İNÖNÜ, Gülgün YENİŞEHİRLİ, Serhat ÇELİKEL, Ayşe YILMAZ, Yunus BULUT, Zehra SEYFİKLİ, Barış OTLU

Primary Drug Resistance and Molecular Epidemiology of the Mycobacterium tuberculosis Strains Isolated in the Kelkit Valley

Aim: The aim of this study was to determine the primary drug resistance rates and genotypes of resistant Mycobacterium tuberculosis strains isolated in the Kelkit Valley. Materials and Methods: Primary resistance to isoniazid (INH), rifampicin (RIF), ethambutol (ETB), and streptomycin (SM) was determined with the BACTEC 460 radiometric system. Forty-eight resistant M. tuberculosis strains isolated from tuberculosis patients living in the Kelkit Valley were genotyped using the spoligotyping method. Results: Approximately 11.6% of the strains were resistant against at least one major drug, and 8.3% were resistant against more than one drug. Single-drug resistance for INH, ETB, SM, and RIF was found as 5.8%, 2.1%, 3.7%, and 0.0%, respectively. Two or more drug resistance rates for SM + ETB, SM + INH, INH + RIF, RIF + ETB, INH + ETB + RIF, SM + ETB + INH and INH + ETB + RIF + SM were determined as 0.8%, 1.7%, 0.4%, 0.8%, 2.9%, 0.4%, and 1.2%, respectively. Fifteen spoligotype groups were created when the results were compared with the world databank (SpoIDB4). Families of four strains could not be determined. The spoligotype groups most frequently encountered in our study were ST4 (n = 10, 20.8%), ST53 (n = 6, 12.5%), ST7 (n = 4, 8.3%), ST41 (n = 4, 8.3%) and ST31 (n = 4, 8.3%), and the most frequently encountered families were TI (n = 18, 37.5%), S (n = 12, 25%) and LAM-7 TUR (n = 4, 8.3%). Conclusions: High rates of primary resistance against major anti-tuberculosis drugs, the LAM-7 TUR clone, and high grouping rates were detected in this study, the first such study carried out in the Kelkit Valley.

Anahtar Kelimeler:

M. tuberculosis, primary drug resistance, molecular epidemiology

Primary Drug Resistance and Molecular Epidemiology of the Mycobacterium tuberculosis Strains Isolated in the Kelkit Valley

Keywords:

M. tuberculosis, primary drug resistance, molecular epidemiology,

PDF

___

1. Durmaz R, Ozerol IH, Durmaz B, Gunal S, Senoğlu A, Evliyaoğlu E. Primary drug resistance and molecular epidemiology of M. tuberculosis isolates from patients in a population with high tuberculosis incidence in Turkey. Microbiol Drug Res 2003; 9: 361–6.
2. T.C. Sağlık Bakanlığı Verem Savaşı Daire Başkanlığı, Türkiye’ de Verem Savaşı 2007 Raporu. Baskı Rekmay Ltd. Şti. Ankara, Mart 2007.
3. Durmaz R. The resistance problem in Mycobacterium tuberculosis. Ankem Derg 2005; 19: 107-10.
4. Bengisun JS, Karnak D, Palabiyikoğlu I, Saygun N. Mycobacterium tuberculosis drug resistance in Turkey, 1976–97. Scand J Infect Dis 2000; 32: 507-10.
5. Pazarli P, Karagöz T, Yazıcıoglu Mocin O, Duman D, Akel G. Drug resistance in pulmonary tuberculosis in Turkey. Eur J Clin Infect Dis 2007; 26: 431-3.
6. Kiliçaslan Z, Albal H, Kiyan E, Aydemir N. Drug resistance in pulmonary tuberculosis in Istanbul. Eur J Clin Microbiol Infect Dis 2002; 21: 763-4.
7. Durmaz R, Zozio T, Gunal S, Yaman A, Cavusoğlu C, Guney C. Genetic diversity and major spoligotype families of drug-resistant Mycobacterium tuberculosis clinical isolates from different regions of Turkey. Infect Genet Evol 2007; 7: 513-9.
8. Koksalan OK, Kiliçaslan Z, Zanlier G, Guzel R, Seber E. Prevalence of Beijing genotype Mycobacterium tuberculosis strains in Istanbul. Int J Tuberc Lung Dis 2006; 10: 469-72.
9. Kisa O, Albay A, Baylan O, Tozkoparan E, Acikel CH, Dogancı L. Genetic diversity of Mycobacterium tuberculosis isolates at the Military Medical Academy in Ankara, Turkey. Res Microbiol 2007; 158: 318-23.
10. Bicmen C, Esen N, Graviss EA, Williams-Bauyer N, Ramaswamy SV, Yulug N. Molecular characterization of Mycobacterium tuberculosis isolates from Izmir, Turkey. New Microbiol 2007; 30: 229-40.
11. Centers for Disease Control: Initial therapy for tuberculosis era of multi-agent resistance: recommendations of Advisory Council for the elimination of tuberculosis. 1993; MMWR 42(R-7): 1-3.
12. Siddiqi SH. BACTEC 460 TB System, Products and Procedure Manual, revision D. Becton Dickinson, Sparks, MD; 1995.
13. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-14.
14. Kolk AH, Schuitema AR, Kuijper S, van Leeuwen J, Hermans PW, van Embden JD et al. Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system. J Clin Microbiol 1992; 30: 2567-75.
15. van Soolingen D, de Haas PE, Hermans PW, Groenen PM, van Embden JD. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 1993; 31: 1987- 95.
16. van Soolingen D, Hermans PW, de Haas PE, Soll DR, vanEmbden JD. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991; 29: 2578- 86.
17. Yew WW, Chau CH. Drug-resistant tuberculosis in the 1990s. Eur Respir J 1995; 8: 1184-92.
18. WHO/IUATLD. Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report No. 2. WHO/CDS/TB/2000. 278.
19. Yolsal N, Malat G, Dişçi R, Örkün M, Kılıçaslan Z. The comparison of 1984-1989 and 1990-1995 years of drug-resistant tuberculosis in Turkey: a meta-analysis. Klimik Derg 1998; 11: 6- 9.
20. World Health Organization. The WHO/IUATLD. Global Project on Antituberculosis Drug Resistance Surveillance: Anti-tuberculosis drug resistance in the world, Third Global Report. Geneva, Switzerland: 2004. WHO/CDS/TB/2004.
21. Nutini S, Tortoli E, Corrado A. Multidrug-resistant tuberculosis in the Florence Province from 1992 to 1995. Int J Tuberc Lung Dis 1998; 2: 484-489.
22. Wang PD, Ling RS. Drug resistant tuberculosis in Taipei, 1996- 1999. Am J Infect Control 2001; 29: 41-7.
23. Zozio T, Allix C, Gunal S, Saribas Z, Alp A, Durmaz R et al. Genotyping of Mycobacterium tuberculosis clinical isolates in two cities of Turkey: description of a new family of genotypes that is phylogeographically specific for Asia Minor. BMC Microbiol 2005; 5: 44.
24. Banu S, Gordon SV, Palmer S, Islam MR, Ahmed S, Alam KM et al. Genotypic analysis of Mycobacterium tuberculosis in Bangladesh and prevalence of the Beijing strain. J Clin Microbiol 2004; 42: 674-82.
25. Aristimuno L, Armengol R, Cebollada A, Espana M, Guilarte A, Lafoz C et al. Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Antituberculosis Drug Resistance from Venezuela. BMC Microbiol 2006; 6: 90.